Reduced Humoral Response of SARS-CoV-2 Antibodies following Vaccination in Patients with Inflammatory Rheumatic Diseases—An Interim Report from a Danish Prospective Cohort Study

Reduced Humoral Response of SARS-CoV-2 Antibodies following Vaccination in Patients with Inflammatory Rheumatic Diseases—An Interim Report from a Danish Prospective Cohort Study

<b>Background/Purpose</b><b>:</b> In light of the current COVID-19 pandemic, whether patients with rheumatic musculoskeletal disease (RMD) treated with conventional (cs) or biologic (b) disease-modifying drugs (DMARDs) exhibit an adequate immune response to the currently avai...

Full description

Bibliographic Details
Main Authors: Karen Schreiber, Christine Graversgaard, Randi Petersen, Henning Jakobsen, Anders Bo Bojesen, Niels Steen Krogh, Bente Glintborg, Merete Lund Hetland, Oliver Hendricks
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Vaccines
Subjects:
COVID-19 vaccine
RMD
humoral response
Online Access:https://www.mdpi.com/2076-393X/10/1/35

Internet

https://www.mdpi.com/2076-393X/10/1/35

Similar Items